These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2505712)

  • 1. [Evaluation of the dose-effect relationship of perindopril in the treatment of arterial hypertension].
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():43-50. PubMed ID: 2505712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the dose-effect relationship of perindopril in the treatment of hypertension.
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Clin Exp Hypertens A; 1989; 11 Suppl 2():521-34. PubMed ID: 2605801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril].
    Forette F; McClaran JM; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():79-85. PubMed ID: 2505717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension.
    West JN; Smith SA; Stallard TJ; Littler WA
    J Hypertens; 1989 Feb; 7(2):97-104. PubMed ID: 2647846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of perindopril.
    Lees KR
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():7-8; discussion 9-11. PubMed ID: 2283658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review of perindopril in the treatment of hypertension.
    Lerebours G; Antony I
    Can J Cardiol; 1994 Nov; 10 Suppl D():3D-7D. PubMed ID: 7954037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
    Widimský J; Fedelesová V; Uhlír O
    Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and acceptability of perindopril in essential hypertension.
    Sukonthasarn A; Ratanaprakarn R; Koanantakul B; Ngam-Ukos P
    J Med Assoc Thai; 1994 Jun; 77(6):281-7. PubMed ID: 7869013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive effect of perindopril. Experimental pharmacology].
    Barthelmebs M; Devissaguet M; Imbs JL
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():17-24. PubMed ID: 2505709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perindopril: first-line treatment of arterial hypertension].
    Zanchetti A; Desche P
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():63-72. PubMed ID: 2505715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment].
    Pieniazek W; Franczuk P; Janicki K
    Przegl Lek; 2001; 58(5):411-4. PubMed ID: 11603173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.
    Rehman A; Ismail SB; Naing L; Roshan TM; Rahman AR
    Am J Hypertens; 2007 Feb; 20(2):184-9. PubMed ID: 17261465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
    Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ambulatory registration of arterial pressure during treatment with perindopril. Effects on systolic pressure and hemodynamic implications].
    Santoni JP; Asmar RG; Bizot-Espiard JG; Safar M
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():51-6. PubMed ID: 2505713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril versus perindopril: a double blind study in essential hypertension.
    Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
    J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
    Letellier P; Overlack A; Agnes E; Desche P
    J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of perindopril: therapeutic consequences.
    Lees KR; Hughes DM; McNeill CA; Reid JL
    Clin Exp Hypertens A; 1989; 11 Suppl 2():499-506. PubMed ID: 2605799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.